Sentonix, Inc. funding

Sentonix, Inc., a pharmaceuticals company based in Arlington, MA (founded 2023), filed a Form D with the SEC on August 20, 2026 and reported $12.7M raised of a $21.2M offering.

Amount raised$12.7M

Offering size$21.2M

Filed with the SECAugust 20, 2026

First saleAugust 13, 2026

IndustryPharmaceuticals

SecuritiesEquity

LocationArlington, MA

Founded2023

Entity typeCorporation

Investors so far17

Minimum investment$250K

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 20

Other health care rounds in Massachusetts

Zai Lab Ltd$250M · Nov 9Biotechnology Typewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology AI3 Bio, Inc.$48.3M · Nov 4Biotechnology Nanopath Inc$29.9M · Nov 13Biotechnology XRHealth, Inc.$22.8M · Sep 16Other Health Care Xact Bio, Inc.$10M · Sep 28Biotechnology Crosslink Therapeutics Inc.$5.5M · Oct 20Pharmaceuticals Fresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care